Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT06651255

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease (WILL-MANAGE)

Algorithm-based Management to Reduce the Recurrence of Gastrointestinal Bleeding and Severe Epistaxis in Von Willebrand Disease: WILL-MANAGE Trial

Sponsor: University Hospital, Lille

Conditions Von Willebrand Disease (VWD)

Interventions Optimized management Standard of care management

Updated 3 times since 2024 Last updated: Mar 10, 2025 Started: Apr 30, 2025 Primary completion: Apr 30, 2034 Completion: Dec 6, 2034

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Von Willebrand Disease (VWD) and is currently actively recruiting participants. University Hospital, Lille leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting NA
Apr 2025 — Sep 2025 [monthly]

Not Yet Recruiting NA
Nov 2024 — Apr 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Lille

Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Brest, France , Bron, France , Caen, France , Chambéry, France , Clermont-Ferrand, France , Dijon, France , Le Kremlin-Bicêtre, France , Lille, France , Marseille, France and 7 more locations